Life Sciences Snapshot – Q4 2024 – A Quarterly Report on Financing Trends

Carsten Bernauer, Josh Beser, Tony Chan, Edward Dyson, Craig Falls, David Gindler, Gregg Griner, Blake Ilstrup, Scott Iyama, Thora Johnson, Amy Joseph, Neel Lilani, Ed Lukins, Mike O'Donnell, Georgia Ravitz, David Schulman, Jeremy Sherer, Gargi Talukder, Stephen Thau, Albert Vanderlaan, Alex Wood
Orrick, Herrington & Sutcliffe LLP
Contact
LinkedIn
Facebook
X
Send
Embed

Since the previous quarter’s Life Sciences Snapshot, robust dealmaking activity in Q3 has launched YTD life sciences VC deal activity to near parity with 2023 figures, firmly positioning 2024 as the year to break the two-year declines in venture activity. This report series examines quarterly trends in life sciences venture investments, and the key takeaways include...

Please see full publication below for more information.

View PDF
Download PDF [2050KB]
Email
Report

LOADING PDF: If there are any problems, click here to download the file.
Send Report

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations. Attorney Advertising.

© Orrick, Herrington & Sutcliffe LLP

Written by:

Orrick, Herrington & Sutcliffe LLP
Orrick, Herrington & Sutcliffe LLP
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

Orrick, Herrington & Sutcliffe LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign Up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide